Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

This publication has 8 references indexed in Scilit:

• Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
  Neuropharmacology, 1998
• Dopamine, the prefrontal cortex and schizophrenia
  Journal of Psychopharmacology, 1997
• Actions of methoxylated amphetamine hallucinogen on serotonergic neurons of the brain
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1996
• In vitro and in vivo profile of SB 206553, a potent 5‐HT_2C/5‐HT_2B receptor antagonist with anxiolytic‐like properties
  British Journal of Pharmacology, 1996
• The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat
  European Journal of Pharmacology, 1995
• Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro
  Brain Research, 1994
• Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized rat
  Neuropharmacology, 1994
• A 5-hydroxytryptamine2 agonist augments γ-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons
  Neuroscience, 1993